Skip to main content
BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.180
-0.025 (-2.07%)
At close: Mar 6, 2026, 4:00 PM EST
1.180
0.00 (-0.01%)
After-hours: Mar 6, 2026, 7:58 PM EST

BioCardia Revenue

In the year 2024, BioCardia had annual revenue of $58.00K, down -87.84%.

Revenue (ttm)
$58.00K
Revenue Growth
-87.84%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
20
Market Cap
12.52M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202458.00K-419.00K-87.84%
Dec 31, 2023477.00K-875.00K-64.72%
Dec 31, 20221.35M337.00K33.20%
Dec 31, 20211.02M870.00K600.00%
Dec 31, 2020145.00K-565.00K-79.58%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BioLineRx 12.74M
BioAtla 11.00M
Traws Pharma 2.85M
CytoMed Therapeutics 573.19K
Can-Fite BioPharma 560.00K
Soligenix 2.34K
Revenue Rankings

BCDA News

More News